Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
1.005
+0.005 (0.50%)
Apr 2, 2025, 3:01 PM EDT - Market open

Cytosorbents Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
55505868182344
Upgrade
Market Cap Growth
-14.14%-14.14%-14.31%-62.87%-47.06%175.66%
Upgrade
Enterprise Value
78716858135272
Upgrade
Last Close Price
1.000.911.111.554.197.97
Upgrade
PS Ratio
1.531.401.591.954.228.39
Upgrade
PB Ratio
4.944.482.491.912.914.34
Upgrade
P/TBV Ratio
4.484.482.992.183.154.59
Upgrade
EV/Sales Ratio
2.201.991.861.693.126.64
Upgrade
Debt / Equity Ratio
2.422.420.790.520.220.01
Upgrade
Asset Turnover
0.710.710.620.450.480.70
Upgrade
Inventory Turnover
3.273.273.913.392.974.62
Upgrade
Quick Ratio
1.081.081.392.864.147.54
Upgrade
Current Ratio
2.202.201.773.484.708.12
Upgrade
Return on Equity (ROE)
-120.52%-120.52%-97.21%-67.00%-34.64%-18.97%
Upgrade
Return on Assets (ROA)
-20.85%-20.85%-32.48%-25.27%-15.84%-11.05%
Upgrade
Return on Capital (ROIC)
-26.36%-26.36%-39.74%-29.69%-18.15%-12.99%
Upgrade
Earnings Yield
-37.89%-41.64%-49.19%-48.51%-13.48%-2.28%
Upgrade
FCF Yield
-26.91%-29.57%-38.29%-50.74%-9.69%-1.84%
Upgrade
Buyback Yield / Dilution
-21.18%-22.10%-2.49%-0.49%-11.70%-20.35%
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q